# Jiangsu JLand Biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-jland-biotech-co

- Industry: Biotechnology
- Headquarters: Jingjiang, China
- Website: www.jlandbiotech.com
- Total disclosed funding: $14M
- Latest round: Series C (May 26, 2025)
- Investors on record: 5

## About

Established in 2015 and based in Jingjiang, China, Jiangsu JLand Biotech Co., Ltd. operates as a biomimetic technology developer that provides non-animal-derived collagen. The company has branches in Hangzhou, Shaoxing, Shanghai and Europe. It cooperated with the Nanjing University of Science and Technology to establish the Jiangsu Recombinant Collagen Engineering Research Center and also cooperates with Fudan University, Huashida University and China Pharmaceutical University. In 2016, the company's recombinant human collagen was industrialized. In March 2023, it was awarded as "InnoCosme Awards Meiyao Award". In March 2025, JLand closed a venture funding from new investors CS Capital and Yuexiu Industrial Investment Funds Management.

JLand mainly provides recombinant human collagen and downstream products based on bioengineering technology such as genetic recombination, microbial fermentation, protein isolation and purification. Its brands include Kemeishi and Demulcent, etc. Products include multi-sphere products, blister lyophilized spheres, syringes lyophilized spheres and lyophilized, and can be applied in cosmetics, nutraceuticals and medical devices fields. Besides, the company also engages in functional skin care products OEM and ODM business. It has many clients, such as Kristina, Huaxi Bio and Davis & Garret. 

The company generates revenue by developing and providing collagen technology and products.

## Funding rounds

- Series C, May 26, 2025, $14M — Yuexiu Industrial Investment Funds Management, CS Capital
- Series B, Sep 25, 2023 — Cenova Ventures, Evonik
- Series A, Jun 30, 2021 — Addor Capital

## Investors

- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A
- Cenova Ventures (https://capitalatlas.ai/funds/cenova-ventures) — Series B
- Evonik — Series B
- Yuexiu Industrial Investment Funds Management (https://capitalatlas.ai/funds/yuexiu-industrial-investment-funds-management) — Series C
- CS Capital — Series C